drugset
drugset / Trial / NCT02884635

A Study to Evaluate the Efficacy and Safety of ASP1707 in Postmenopausal Female Patients With Rheumatoid Arthritis Taking Methotrexate

NCT02884635 ↗

Phase 2 Completed 72 enrolled Astellas Pharma Inc
RandomizedParallel-groupDouble-blindTreatment

Summary

The objective of this study is to evaluate the efficacy, pharmacokinetics, pharmacodynamics and safety of ASP1707 in combination with MTX in postmenopausal female patients with RA.

Timeline

Start
2016-09-16
Primary completion
2017-10-18
Completion
2017-10-25

Drugs

EvaluationDrugModalityDoseRoute
Subject OPIGOLIX Other / unclassified — Oral
Background Methotrexate Small molecule — Oral

Indications

rheumatoid arthritis